Flagship explainer
How ORAMED PHARMACEUTICALS INC. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $2M | 100% |
| |
| Cost of revenue | $2M | 99% |
|
| $13000 | 1% |
| |
| −$15.1M | −754% |
| |
| Income before tax | $75.3M | 3766% |
|
| Income tax | $11.3M | 565% |
|
| $64M | 3203% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001213900-26-034835